{"id":"https://openalex.org/W2060249257","doi":"https://doi.org/10.1021/op020205n","title":"A Scaleable Synthesis of BAY 43-9006: A Potent Raf Kinase Inhibitor for the Treatment of Cancer","display_name":"A Scaleable Synthesis of BAY 43-9006: A Potent Raf Kinase Inhibitor for the Treatment of Cancer","alternate_titles":[],"publication_year":2002,"publication_date":"2002-09-20","ids":{"openalex":"https://openalex.org/W2060249257","doi":"https://doi.org/10.1021/op020205n","mag":"2060249257"},"language":"en","primary_location":{"id":"doi:10.1021/op020205n","doi":"https://doi.org/10.1021/op020205n","is_oa":false,"landing_page_url":"https://doi.org/10.1021/op020205n","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research &amp; Development","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2060249257"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049214635","display_name":"Donald D. Bankston","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Donald Bankston","raw_affiliation_strings":["Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jacques Dumas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacques Dumas","raw_affiliation_strings":["Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081477980","display_name":"Reina Natero","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Reina Natero","raw_affiliation_strings":["Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006281057","display_name":"Bernd Riedl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bernd Riedl","raw_affiliation_strings":["Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113213939","display_name":"Mary-Katherine Monahan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mary-Katherine Monahan","raw_affiliation_strings":["Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069744256","display_name":"Robert Sibley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert Sibley","raw_affiliation_strings":["Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Research Center, Pharmaceutical Division, 400 Morgan Lane, West Haven, Connecticut 06516, U.S.A","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.4417,"has_fulltext":false,"cited_by_count":119,"citation_normalized_percentile":{"value":0.53851884,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":99},"biblio":{"volume":"6","issue":"6","first_page":"777","last_page":"781"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.328900009393692,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.328900009393692,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.14810000360012054,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.13950000703334808,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/raf-kinase-inhibitors","display_name":"Raf kinase inhibitor","score":0.7739999890327454},{"id":"https://openalex.org/keywords/urea-synthesis","display_name":"urea synthesis","score":0.7419999837875366},{"id":"https://openalex.org/keywords/scalable-synthesis","display_name":"scalable synthesis","score":0.7559999823570251},{"id":"https://openalex.org/keywords/process-research","display_name":"process research","score":0.6779999732971191},{"id":"https://openalex.org/keywords/chromatography-free-purification","display_name":"chromatography-free purification","score":0.6610000133514404},{"id":"https://openalex.org/keywords/intermediate-isolation","display_name":"intermediate isolation","score":0.5920000076293945},{"id":"https://openalex.org/keywords/anticancer-drug-production","display_name":"anticancer drug production","score":0.5630000233650208},{"id":"https://openalex.org/keywords/preclinical-toxicology","display_name":"preclinical toxicology","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C134121241","wikidata":"https://www.wikidata.org/wiki/Q899301","display_name":"Yield (engineering)","level":2,"score":0.6140245199203491},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5933188796043396},{"id":"https://openalex.org/C2780365088","wikidata":"https://www.wikidata.org/wiki/Q48318","display_name":"Urea","level":2,"score":0.5789297223091125},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5264645218849182},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4477708339691162},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4341391324996948},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.41458308696746826},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34299713373184204},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2527889609336853},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19491782784461975},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1509581208229065},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.055945247411727905},{"id":"https://openalex.org/C191897082","wikidata":"https://www.wikidata.org/wiki/Q11467","display_name":"Metallurgy","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1021/op020205n","doi":"https://doi.org/10.1021/op020205n","is_oa":false,"landing_page_url":"https://doi.org/10.1021/op020205n","pdf_url":null,"source":{"id":"https://openalex.org/S107255770","display_name":"Organic Process Research & Development","issn_l":"1083-6160","issn":["1083-6160","1520-586X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Process Research &amp; Development","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1983691718","https://openalex.org/W1987013746","https://openalex.org/W2015837676","https://openalex.org/W2030889696","https://openalex.org/W2060942794","https://openalex.org/W2094804194","https://openalex.org/W2146090212","https://openalex.org/W2949576762"],"related_works":["https://openalex.org/W2052550764","https://openalex.org/W3027556893","https://openalex.org/W2091565432","https://openalex.org/W1999929168","https://openalex.org/W2391449329","https://openalex.org/W2950212793","https://openalex.org/W1995416161","https://openalex.org/W2809595093","https://openalex.org/W1981737774","https://openalex.org/W2322111116"],"abstract_inverted_index":{"Urea":[0],"3":[1,63],"(":[2],"BAY":[3],"43":[4],"-":[5],"9006":[6],"),":[7],"a":[8],"potent":[9],"Raf":[10],"kinase":[11],"inhibitor,":[12],"was":[13],"prepared":[14],"in":[15],"four":[16],"steps":[17],"with":[18],"an":[19],"overall":[20,38],"yield":[21,39],"of":[22,29,59,62],"63%.":[23],"Significant":[24],"process":[25],"research":[26],"enabled":[27],"isolation":[28],"each":[30],"intermediate":[31],"and":[32,37],"target":[33],"without":[34],"chromatographic":[35],"purification,":[36],"increases":[40],">50%":[41],"were":[42],"observed":[43],"compared":[44],"to":[45,73,82],"those":[46],"from":[47],"previous":[48],"methods.":[49],"This":[50],"report":[51],"focuses":[52],"on":[53],"improved":[54],"synthetic":[55],"strategies":[56],"for":[57,64],"production":[58],"scaled":[60],"quantities":[61],"preclinical,":[65],"toxicological":[66],"studies.":[67],"These":[68],"improvements":[69],"may":[70],"be":[71],"useful":[72],"assemble":[74],"other":[75],"urea":[76],"targets":[77],"as":[78],"potential":[79],"therapeutic":[80],"agents":[81],"combat":[83],"cancer.":[84]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2060249257","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
